Abdullah, Wahida B.
HRN: 21-29-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2023
CO-AMOXICLAV 625MG (TAB)
06/18/2023
06/25/2023
ORAL
625 Mg
BID
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes